Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
Director departure
CC transcript
|
|
ALBIREO PHARMA, INC. (ALBO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
SC 13G/A
| BlackRock Inc. reports a 2.4% stake in ALBIREO PHARMA, INC. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 2% stake in Albireo Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 8.5% stake in Albireo Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| Deep Track Capital, LP reports a 8.2% stake in Albireo Pharma, Inc. |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 12.2% stake in Albireo Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 12.2% stake in ALBIREO PHARMA, INC. |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 12.4% stake in Albireo Pharma, Inc. |
| 02/16/2021 |
SC 13G/A
| ArrowMark Colorado Holdings LLC reports a 3.9% stake in Albireo Pharma, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Satter Muneer A reports a 0% stake in Albireo Pharma, Inc. |
| 02/14/2020 |
SC 13G/A
| Arrowpoint Asset Management, LLC reports a 6.8% stake in Albireo Pharma, Inc. |
| 02/14/2020 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 13.4% stake in Albireo Pharma, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Satter Muneer A reports a 5.6% stake in Albireo Pharma, Inc. |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 14.2% stake in Albireo Pharma, Inc. |
| 02/13/2019 |
SC 13G/A
| Satter Muneer A reports a 7% stake in Albireo Pharma, Inc. |
| 02/09/2018 |
SC 13G/A
| Satter Muneer A reports a 7.7% stake in Albireo Pharma, Inc. |
| 12/04/2017 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 14.8% stake in Albireo Pharma, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/16/2016 |
SC 13G/A
| Rock Springs Capital Management LP reports a 0% stake in Biodel Inc |
| 02/14/2012 |
SC 13G/A
| Biodel Inc reports a 10% stake in Biodel Inc. |
| 01/12/2011 |
SC 13G/A
| Biodel Inc reports a 4.6% stake in Biodel Inc. |
| 12/10/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 07/09/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/16/2010 |
SC 13G/A
| Moab Partners LP reports a 9.9% stake in Biodel Inc. |
| 02/16/2010 |
SC 13G/A
| GREAT POINT PARTNERS I LP reports a 4.9% stake in Biodel Inc. |
| 02/16/2010 |
SC 13G/A
| STEINER VENTURES LLC reports a 18.1% stake in Biodel Inc. |
| 12/31/2009 |
SC 13G/A
| Poco Bay Co reports a 0% stake in Biodel Inc. |
| 02/17/2009 |
SC 13G/A
| FMR CORP reports a 10.3% stake in Biodel Inc. |
| 02/17/2009 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Biodel Inc. |
|
|